AMP Certificate Programs

Pharmacogenomics: Genes, Drugs, and Genotyping: AMP Pharmacogenomics Guidelines

Pharmacogenomics is an important and evolving area of medical testing that combines pharmacology and genomics to identify genomic variability that can affect individual drug response. There is a need in the general medical and laboratory communities to understand the fundamentals of pharmacogenomics and the impacts of molecular testing on optimizing drug selection. This certificate program is intended to provide an introduction to pharmacogenomics and to review AMP expert consensus recommendations for standardization of alleles for clinical pharmacogenomic genotyping assays.

NGS101 v2.0: A Re-Introduction to the Fundamentals of Next-Generation Sequencing

This AMP Certificate Program is an update of the very popular NGS101. Whether you’re looking to add Next-Generation Sequencing (NGS) to your lab or need a refresher, this course delivers the most current and useful information to help you in your decision making process. This 7-part course (including 6.50 hrs of CME or CMLE credit) is a comprehensive primer on implementing and running NGS in your laboratory.

Molecular Laboratory Management and Reporting: A Short Course for Laboratory Professionals

While most molecular pathology professionals receive a deep foundation in science and clinical practice, there is still a critical need for training in laboratory management and the soft skills required for operational effectiveness. This certificate program will provide an overview of best practices in many areas of laboratory management and reporting.

Next Generation Bioinformatics: Beyond Simple Variant Calling

This certificate program is designed to give participants a deep dive into the challenges and proposed solutions in bioinformatics for next generation sequencing (NGS) testing. The talks go beyond the typical basics in bioinformatics of detecting simple point mutations and small indels into harder-to-detect genomic anomalies. The talks in this Certificate Program discuss common problems and challenges seen in NGS data. These include strand bias, false positives, homology to interpretation challenges with databases, and HGVS nomenclature and proposed solutions for each of these. Speakers present a closer look at complex bioinformatics pipelines from selected laboratories, as well as an overview of advanced methods and technologies to detect complicated genomic anomalies. These anomalies include structural variants, copy number calling and fusion detection using both short and long read sequencing, as well as DNA and RNA assays.

Hot Topics in Infectious Disease

The ability to understand the world through the use of molecular tools has led to fascinating discoveries in the field of microbiology and infectious diseases. In this certificate program, participants will learn about the current state-of-the-art infectious disease topics with the emphasis on the key topics and advances in infectious disease testing and their impact on patient care practices and in public health. This certificate program will review updates on what's new in sexually transmitted disease (STD) care, rapid diagnostics point of care tests, metagenomics also known as microbiome and its impact of bacterial diversity (microbiome), and human health by using next- generation sequencing.

Circulating Tumor DNA Testing: Advances, Challenges, and Applications

This AMP certificate program, featuring expert speakers in the field, will: define circulating tumor DNA, explain technical challenges, describe approaches for assay design and validation, highlight clinical applications of testing, and will review selected new published studies and guidelines.

2016 World Health Organization (WHO) Updates in Hematologic Malignancies

This AMP certificate program will cover the major changes made in the 2016 WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. Participants will learn from experts in the field covering the following topics: B lymphoid neoplasms, Peripheral T cell lymphomas, Acute Leukemias, Myeloproliferative Neoplasms, Myelodysplastic syndromes and Myelodysplastic/myeloproliferative neoplasms.

Corporate Partners